Tassos Gianakakos
2015
In 2015, Tassos Gianakakos earned a total compensation of $1.4M as President, Chief Executive Officer and Director at MyoKardia, a 192% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,570 |
|---|---|
| Option Awards | $836,432 |
| Salary | $405,600 |
| Other | $500 |
| Total | $1,428,102 |
Gianakakos received $836.4K in option awards, accounting for 59% of the total pay in 2015.
Gianakakos also received $185.6K in non-equity incentive plan, $405.6K in salary and $500 in other compensation.
Rankings
In 2015, Tassos Gianakakos' compensation ranked 6,234th out of 13,638 executives tracked by ExecPay. In other words, Gianakakos earned more than 54.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,234 out of 13,638 | 54th |
Division Manufacturing | 2,334 out of 5,190 | 55th |
Major group Chemicals And Allied Products | 842 out of 1,854 | 55th |
Industry group Drugs | 674 out of 1,528 | 56th |
Industry Pharmaceutical Preparations | 526 out of 1,182 | 56th |
Source: SEC filing on April 25, 2017.
Gianakakos' colleagues
We found two more compensation records of executives who worked with Tassos Gianakakos at MyoKardia in 2015.